At the Atlantic, Ed Yong reports that the Trump Administration is considering capping NIH's indirect cost payments at 10 percent.
The New York Times writes that direct-to-consumer genetic tests could strain long-term care insurers.
House science committee members call on Trump to appoint a White House Office of Science and Technology Policy director, according to Popular Science.
In Science this week: malaria resistance variants, and more.
In a hearing, US lawmakers noted their dissatisfaction with proposed NIH budget cuts, according to ScienceInsider.
The Retraction Watch co-creators warn about contaminated and counterfeit lab supplies in a Stat News column.
In Nature this week: PGBD5 involved in many pediatric solid tumors, and more.
The former commissioner of the US Food and Drug Administration, Robert Califf, is heading to Alphabet's Verily.
Two Australian organizations are appealing a patent covering much of the cattle genome, according to ABC.
According to the San Francisco Chronicle, insurance companies are behind the increase in genetic testing.
In Genome Biology this week: Mycobacterium tuberculosis population dynamics, mapping precision in GWAS, and more.
David Lipman, who has led the US National Center for Biotechnology Information for decades, is stepping down.
Researchers find that energy drinks could be dangerous for patients with familial long QT syndrome, according to Live Science.
BBC News explores services that test consumers' DNA to tailor fitness and nutrition programs.
In PNAS this week: functional genomic study of effects of anti-parasitic drugs, humped bladderwort genome assembly, and more.
Henri Termeer, the former long-time head of Genzyme and "founder of the modern biotech industry," has died, the Boston Globe reports.
The Trump administration is considering choosing a non-scientist to oversee the USDA's Research, Education, and Economics division, Mashable reports.
New bills have been introduced across the US that aim to alter science education standards, according to Nature News.
In PLOS this week: blood pressure and hypertension loci in people of African ancestry, Plasmodium vivax population genomics, and more.
Researchers have found a link between the microbiome and certain brain malformations, according to the New York Times.
After putting off his doctoral studies to find rock-and-roll fame, the Offpring's Dexter Holland graduated this week with a Ph.D. in molecular biology from USC.
UK researchers have dug into the archive to find more cancer samples for sequencing, Nature News reports.
In Science this week: a protective gene in C. elegans, and combining EHRs with genetic data to ID HLA-associated variants
Biotech and academic leaders met with Trump administration officials to discuss NIH funding, ScienceInsider reports.
New membership rules by PhRMA governing R&D spending come as the industry tries to change its image as profiteers of sickness and disease.
Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.
CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.
Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.
Social scientists report that the image of the 'lone scientist' might be deterring US students from STEM careers.